Katrien joined Rabo Investments in 2025, bringing a strong background in life sciences and venture capital. Previously, she was New Venture Director at Kurma Partners and Manager of New Ventures at VIB (Vlaams Instituut voor Biotechnologie). She has served on the boards of Meiogenix, Bar.on, and Protealis. Earlier in her career, she was an advisor in life sciences at IWT, managing due diligence projects and financial analyses for Flemish biotech companies. Katrien holds a Ph.D. from Ghent University, a Master’s degree in Bio-engineering from Ghent University, and a postgraduate degree in Industrial Corporate Policy from EHSAL Management School. She is committed to addressing climate change and supports companies focused on environmental innovation.
BioTech, Climate
📍 Ansässig in Utrecht
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...